ACOU logo

AcouSort AB (publ) Stock Price

OM:ACOU Community·SEK 89.1m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

ACOU Share Price Performance

SEK 4.21
1.13 (36.69%)
SEK 4.21
1.13 (36.69%)
Price SEK 4.21

ACOU Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with slight risk.

4 Risks
2 Rewards

AcouSort AB (publ) Key Details

SEK 10.1m

Revenue

SEK 148.0k

Cost of Revenue

SEK 9.9m

Gross Profit

SEK 20.4m

Other Expenses

-SEK 10.5m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
-0.50
98.53%
-104.46%
0%
View Full Analysis

About ACOU

Founded
2010
Employees
11
CEO
Torsten Freltoft
WebsiteView website
www.acousort.com

AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, a module that enables in-line analysis of blood plasma from whole blood samples; Acoustic Separation Module, a microfluidic solution that provides continuous separation, washing or up-concentration of cells; Acoustic Trapping Module, a microfluidic cell sorters or quality control systems for bioreactors and cell therapy production; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has a collaboration agreement with Moeller Medical to exhibit a prototype system for analyzing separation of cells from body fluids. AcouSort AB (publ) was incorporated in 2010 and is based in Lund, Sweden.

Recent ACOU News & Updates

Recent updates

No updates